Skip to main content
. 2020 Jun 12;9(6):126. doi: 10.3390/biology9060126

Table 3.

The regulation of STAT3 by miRs in gastric cancer.

MiiR MiR Type Cancer Cell Line Effect on STAT3 Major Outcomes Refs
MiR-143 Onco-suppressor GC cell lines (AGS, SNU-1, SNU-5, SNU-16, NCIN87 and KATOIII) Downregulation Disrupting the proliferation and invasion of cancer cells [96]
MiR-125a Onco-suppressor Human GC cell lines MKN45, SGC7901 and NCI-N87 Downregulation Reducing the expression of HAS1 and interfering with the migration of cancer cells [99]
MiR-375 Onco-suppressor Human GC cell lines BGC-823, AGS, SGC-7901 and MKN-45 Downregulation Inhibiting proliferation and migration via STAT3 downregulation [105]
MiR-148a Onco-suppressor GC cell lines SNU-1 (ATCC: CRL-5971), SNU-16 (ATCC: CRL-5974), AGS (ATCC: CRL-1739), NCI-N87 (ATCC: CRL-5822) and KATOIII (ATCC: HTB-103) Downregulation Suppressing growth and metastasis by the downregulation of CCK-BR via STAT3 downregulation [108]
MiR-874 Onco-suppressor Human GC cell lines AGS and BGC823, MKN28 and SGC-7901, as well as the human normal gastric epithelial cell line GES-1 Downregulation Disrupting the STAT3/VEGF axis
Inhibition of angiogenesis and the malignancy of cancer cells
[117]
MiR-216a Onco-suppressor Normal human gastric epithelium cell line (GES-1) and GC cell lines (SGC-7901, MGC-803, MKN-28 and BGC-823) Downregulation Suppressing the metastasis of cancer cells via disrupting the STAT3/EMT axis [121]
MiR-93-5p Oncogene AGS and HEK293 cells Upregulation Downregulation of the STAT3/MMP-9 axis
Inhibition of metastasis and invasion
[127]
MiR-18a Oncogene Human GAC cell lines MKN28 and MKN1 Upregulation STAT3 induction
Promoting the malignant behavior of cancer cells
[131]
MiR-155 Oncogene Human GC cell lines BGC-823, NCI-N87, SGC-7901, AGS, MKN-45 and immortalized gastric mucosa epithelial cell line GES-1 Upregulation Stimulation of STAT3
Activation of MMP-2 and MMP-9
Enhancing invasion and migration of cancer cells
[132]
MiR-106a-3p Oncogene Human GC cell line including SGC-7901 and BGC-823 Upregulation Stimulation of aptinib resistance
Activation of JAK2/STAT3 signaling
SOCS2, SOCS4 and SOCS5 downregulation
[133]